Literature DB >> 19095202

Prospects for dietary therapy of recurrent nephrolithiasis.

David S Goldfarb1.   

Abstract

The goal of this article is to propose a randomized controlled trial (RCT) that tests a hypothesis that dietary manipulation prevents recurrent kidney stones. Dietary interventions based on epidemiologic and pathophysiologic data are reviewed. The only diet trial successful in preventing stones showed that calcium intake of 1,200 mg/d, accompanied by restriction of animal protein, salt, and oxalate ingestion, was superior to 400 mg of calcium and restricted oxalate intake. This study may be worth repeating in women and in a society in which salt restriction might be less effective (eg, United States). The net result of diet trials establishes significant positive effects on urine chemistries, but these have not yet shown efficacy with regard to stone recurrence. Oxalate restriction alone could be effective, but many questions regarding which populations to study are not defined, and dietary oxalate's contribution to stone formation is disputed. Would such a study be limited to patients identified as having high dietary oxalate intake or high intestinal oxalate absorption? Would colonization with Oxalobacter formigenes influence the result? The increased prevalence of stones is linked to weight gain and obesity, making weight loss a possible therapy to prevent stones. Randomized trials show that diets consisting of low-fat content or low-caloric content cause modest weight loss and might be effective in reducing stone formation. Because the efficacy of thiazides in the prevention of stones in patients with hypercalciuria is clear, I propose dietary comparison of higher calcium intake to thiazides for the prevention of calcium-based kidney stones.

Entities:  

Mesh:

Year:  2009        PMID: 19095202     DOI: 10.1053/j.ackd.2008.10.010

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  10 in total

1.  SaRNA-mediated activation of TRPV5 reduces renal calcium oxalate deposition in rat via decreasing urinary calcium excretion.

Authors:  Tao Zeng; Xiaolu Duan; Wei Zhu; Yang Liu; Wenqi Wu; Guohua Zeng
Journal:  Urolithiasis       Date:  2017-08-03       Impact factor: 3.436

2.  Update on the evaluation of repeated stone formers.

Authors:  Adam O Kadlec; Thomas M Turk
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

Review 3.  Kidney stones: an update on current pharmacological management and future directions.

Authors:  Hongshi Xu; Anna L Zisman; Fredric L Coe; Elaine M Worcester
Journal:  Expert Opin Pharmacother       Date:  2013-03       Impact factor: 3.889

Review 4.  Epidemiology of stone disease across the world.

Authors:  Igor Sorokin; Charalampos Mamoulakis; Katsuhito Miyazawa; Allen Rodgers; Jamsheer Talati; Yair Lotan
Journal:  World J Urol       Date:  2017-02-17       Impact factor: 4.226

5.  Quantitative analysis of colonization with real-time PCR to identify the role of Oxalobacter formigenes in calcium oxalate urolithiasis.

Authors:  Ertan Batislam; Erdal Yilmaz; Ercan Yuvanc; Ozgul Kisa; Ucler Kisa
Journal:  Urol Res       Date:  2012-01-04

Review 6.  Dietary recommendations and treatment of patients with recurrent idiopathic calcium stone disease.

Authors:  W G Robertson
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

Review 7.  Medical and alternative therapies in urinary tract stone disease.

Authors:  Ercan Yuvanc; Erdal Yilmaz; Devrim Tuglu; Ertan Batislam
Journal:  World J Nephrol       Date:  2015-11-06

8.  A Single Nucleotide Polymorphism (rs4236480) in TRPV5 Calcium Channel Gene Is Associated with Stone Multiplicity in Calcium Nephrolithiasis Patients.

Authors:  Anas Khaleel; Mei-Shin Wu; Henry Sung-Ching Wong; Yu-Wen Hsu; Yii-Her Chou; Hsiang-Yin Chen
Journal:  Mediators Inflamm       Date:  2015-05-18       Impact factor: 4.711

9.  Biochemical and Pathological Study of Hydroalcoholic Extract of Achillea millefolium L. on Ethylene Glycol-Induced Nephrolithiasis in Laboratory Rats.

Authors:  Hassan Hassani Bafrani; Yekta Parsa; Soheila Yadollah-Damavandi; Ehsan Jangholi; Soheil Ashkani-Esfahani; Mohammad Gharehbeglou
Journal:  N Am J Med Sci       Date:  2014-12

10.  A polymorphism in the 3'-untranslated region of the matrix metallopeptidase 9 gene is associated with susceptibility to idiopathic calcium nephrolithiasis in the Chinese population.

Authors:  Qiang Bu; Yu Zhu; Qiao-Yun Chen; Hao Li; Yan Pan
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.